P030: Baseline IgM amount can identify patients with adverse outcome despite a PET-2 adapted treatment in classical Hodgkin Lymphoma: results from a real-life single-center study i

Authors: Alessandra Romano, Claudio Cerchione, Gabriella Santuccio, Marialudovica Le Moli, Annalisa Chiarenza, Amalia Figuera, Giovanna Motta, L. Caruso, Sofia Lanza, A. Petronaci, S. Poidomani, Massimo Ippolito, Francesco Di Raimondo

Published: 2022-10-10

DOI: 10.1097/01.hs9.0000890688.01421.7a

Source: Full article

---

Abstract

No abstract found.